Scholarlink

<p>We sought to assess the validity of risk stratification table of Japanese Society of Hypertension (JSH) 2025 guideline, based on Scheie hypertensive fundus changes. We analyzed the data of medical checkup of Saitama Red Cross Hospital from 2017 to 2024 who underwent fundus examination (<i>N</i> = 6953). Based on the risk stratification table of JSH 2025 guideline, age, sex, comorbidities, past history, and blood pressure (BP) at the health checkup examination were used to stratify the risk into 12 groups. As the original of this study, those with BP &lt; 130/80 mmHg were further examined and a total of 15 groups were analyzed. Risk 1st category and BP &lt; 130/80 mmHg were set as a control group. As the risk category and BP level each increased, the rate of Scheie hypertensive changes significantly increased. Samely, the rate of Scheie sclerotic changes also significantly increased. In the range of BP &lt; 130/80 mmHg, the rate of fundus changes significantly increased as the risk category increased. In conclusion, the risk stratification table of JSH 2025 guideline was valid based on Scheie hypertensive changes in subjects with medical checkup. Furthermore, those with BP &lt; 130/80 mmHg could be added in the risk stratification table.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Validity of risk stratification of JSH 2025 guideline based on hypertensive retinal changes

  • 期刊论文

  • 发表日期：

    2026年3月6日

查看全文
  • Kazuo Eguchi,
  • Kimiko Okinaga,
  • Harumi Ukai

摘要

We sought to assess the validity of risk stratification table of Japanese Society of Hypertension (JSH) 2025 guideline, based on Scheie hypertensive fundus changes. We analyzed the data of medical checkup of Saitama Red Cross Hospital from 2017 to 2024 who underwent fundus examination (N = 6953). Based on the risk stratification table of JSH 2025 guideline, age, sex, comorbidities, past history, and blood pressure (BP) at the health checkup examination were used to stratify the risk into 12 groups. As the original of this study, those with BP < 130/80 mmHg were further examined and a total of 15 groups were analyzed. Risk 1st category and BP < 130/80 mmHg were set as a control group. As the risk category and BP level each increased, the rate of Scheie hypertensive changes significantly increased. Samely, the rate of Scheie sclerotic changes also significantly increased. In the range of BP < 130/80 mmHg, the rate of fundus changes significantly increased as the risk category increased. In conclusion, the risk stratification table of JSH 2025 guideline was valid based on Scheie hypertensive changes in subjects with medical checkup. Furthermore, those with BP < 130/80 mmHg could be added in the risk stratification table.